Episode 29 - Days 1 and 2: Key Breakthroughs from EASL 2026
Failed to add items
Add to basket failed.
Add to wishlist failed.
Remove from wishlist failed.
Adding to library failed
Follow podcast failed
Unfollow podcast failed
Episode 29 - Days 1 and 2: Key Breakthroughs from EASL 2026
-
Narrated by:
-
By:
These podcast episodes explore the rapidly evolving treatment landscape of Primary Biliary Cholangitis, highlighting recent therapeutic advances and reviews emerging clinical evidence on promising investigational therapies.
Designed for healthcare professionals, these episodes provides expert commentary on the latest cutting-edge data presented at EASL Congress 2026. Through an engaging podcast format, listeners will gain practical insights into how new evidence can inform personalized treatment strategies, support improved patient outcomes, and enhance the overall quality of care for people living with PBC.
Launch Date/Release: June 3, 2026
Expiration Date: May 31, 2027
FACULTY
Kris V. Kowdley, MD, AGAF, FAASLD, FACG, FACP
Liver Institute Northwest
Director, Velocity Clinical Research
Medical Director and Senior Scientific Advisor
Washington State University
Elson S. Floyd College of Medicine – Professor
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.